Medicis Dynacin Superiority Claims To Minocin "Misbrand" Product - FDA
Executive Summary
Medicis' claims of superiority for its branded-generic Dynacin to Lederle's innovator product Minocin are cited by FDA in a Dec. 22 warning letter issued to the dermatological generic drug firm.